A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight

Completed · Phase 2 · Has a placebo group

Conditions studied: Weight Management, Treatment Of Obesity

In brief

Study of whether the investigational drug CE-326,597 improves glucose control and results in body weight loss in patients with type 2 diabetes

Key facts

Study ID

NCT00542009

Run by

Pfizer

People needed

252

Starts

2007-12-01

Expected to finish

2008-11-01

Last updated by the study team

2012-11-07

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with type 2 diabetes, not on any or on oral (up to 2) anti-diabetic medications, otherwise medically stable.

You may not qualify if…

• Women of childbearing potential, people with unstable medical conditions, people with gallstones

Where it is running

• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — National City, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Conyers, Georgia, United States
• Pfizer Investigational Site — Honolulu, Hawaii, United States
• Pfizer Investigational Site — Idaho Falls, Idaho, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Overland Park, Kansas, United States
• Pfizer Investigational Site — Bethesda, Maryland, United States
• Pfizer Investigational Site — Chaska, Minnesota, United States
• Pfizer Investigational Site — Minneapolis, Minnesota, United States
• Pfizer Investigational Site — Jackson, Mississippi, United States
• Pfizer Investigational Site — Henderson, Nevada, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Fargo, North Dakota, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Lansdale, Pennsylvania, United States
• Pfizer Investigational Site — Rapid City, South Dakota, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.